| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.023 | 0.8 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |